Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Hatzis

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Cancer Research|July 13, 2014
Enhancing reproducibility in cancer drug screening: how do we move forward?Christos Hatzis, Philippe L Bedard, Nicolai J Birkbak, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Molecular Cancer Therapeutics|March 16, 2017
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation InhibitorCasey G Langdon, James T Platt, Robert E Means, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapyW Fraser Symmans, Florentia Peintinger, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
F1000Research|September 23, 2017
Revisiting inconsistency in large pharmacogenomic studiesZhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancerW Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
JAMA Oncology|June 15, 2018
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical TrialRyan L Powles, David Redmond, Christos Sotiriou, et al.
Oncotarget|March 17, 2016
Mutation based treatment recommendations from next generation sequencing data: a comparison of web toolsJaymin M Patel, Joshua Knopf, Eric Reiner, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Cancer Research|July 13, 2014
Enhancing reproducibility in cancer drug screening: how do we move forward?Christos Hatzis, Philippe L Bedard, Nicolai J Birkbak, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
Molecular Cancer Therapeutics|March 16, 2017
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation InhibitorCasey G Langdon, James T Platt, Robert E Means, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapyW Fraser Symmans, Florentia Peintinger, Christos Hatzis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
F1000Research|September 23, 2017
Revisiting inconsistency in large pharmacogenomic studiesZhaleh Safikhani, Petr Smirnov, Mark Freeman, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancerW Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
JAMA Oncology|June 15, 2018
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical TrialRyan L Powles, David Redmond, Christos Sotiriou, et al.
Oncotarget|March 17, 2016
Mutation based treatment recommendations from next generation sequencing data: a comparison of web toolsJaymin M Patel, Joshua Knopf, Eric Reiner, et al.
Pageof 10